Globus Medical Inc expected to post earnings of 61 cents a share - Earnings Preview

Globus Medical

16/02/2024 22:00

* Globus Medical Inc  GMED.N   GMED.K  is expected to show a
rise
in quarterly revenue when it reports  results on February 20 for
the period ending December 31 2023
    * The Audubon Pennsylvania-based  company is expected to
report a
121.2% increase in revenue to $607.095 million from $274.5
million a year ago, according to the mean estimate from 14
analysts, based on LSEG data.The company's guidance on January
10 2024, for the period ended December 31, was for revenue of
$615.500 million.
    * ​LSEG's mean analyst estimate for Globus Medical Inc is
for
earnings of 61 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 9
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Globus
Medical
Inc is $59.50​, above​ its last closing price of $53.82. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.56        0.57       0.57      Met     -0.3
 Jun. 30 2023  0.60        0.59       0.63      Beat    6.2
 Mar. 31 2023  0.51        0.51       0.53      Beat    4.2​
 Dec. 31 2022  0.57        0.56       0.59      Beat    5.3
 ​​Sep.        0.52        0.52       0.50      Missed  -3.9
 30 2022                                                
 Jun. 30 2022  0.54        0.53       0.56      Beat    4.9​
 Mar. 31 2022  0.47        0.47       0.42      Missed  -10.2
 Dec. 31 2021  0.47        0.47       0.49      Beat    3.7
 This summary was machine generated February 16 at 22:00 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)